Gryphon Financial Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-114
Closed -$14K 917
2018
Q2
$14K Sell
114
-8
-7% -$982 0.01% 449
2018
Q1
$14K Sell
122
-32
-21% -$3.67K 0.01% 453
2017
Q4
$18K Buy
+154
New +$18K 0.01% 427